Dow Stock Eyes Key Trendline After Guidance Update

Options traders are quite bullish on JNJ despite lackluster performance in 2023

Fernanda Horner

Digital Content Manager

Dec 5, 2023 at 9:15 AM

Johnson & Johnson (NYSE:JNJ) is in focus this morning, after the pharma giant offered up its guidance for 2024 and beyond. The company is counting on strong demand for its cancer treatments Darzalex and Carvykti, as well as sales of psoriasis drug Stelara, to bolster revenue growth between 5-6% in 2024. The Dow member has been favoring its drugs and medical devices business as it shifts focus away from its consumer health unit.

JNJ is off by 0.3% before the open, but yesterday settled at its highest level since Sept. 25. The equity has added 9.4% off its Oct. 27 three-year low of $144.95, but the bounce has now run into resistance at its 200-day moving average. Year-to-date, JNJ is down 10.1%, another potential hurdle to keep an eye on.

Options traders are overwhelmingly bullish on Johnson & Johnson stock. Over at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), JNJ's 50-day call/put volume ratio of 2.59 is higher than al readings from the past year. This means calls have been picked up at a much quicker-than-usual rate.

It's also worth noting that the equity has tended to exceed these volatility expectations on an annual basis, per its elevated Schaeffer's Volatility Scorecard (SVS) of 97 out of 100.

Follow @Schaeffers

Are You Ready for AI's Potential Supercycle Phase?
Amazon's Jeff Bezos surprised investors when he revealed that one emerging technology is the key to Amazon's future success... This technology could be worth $80 trillion by 2030. Learn more and join Motley Fool's Stock Advisor for 50% off!

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.